Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JG, I tend to agree.. prior posts of mine declared " dead money."
I'm in deep here, likely holding the most shares on this board. Most days I'm calm, a few rattled... calmer when the company communicates. Rattled when my losses increase by tens of thousands.
I don't believe in hope and prayer, just management being honest, forthright, and successful.
JGrumby, not a reasonable shareholder/investor response.
There are several methods of value. The internal valuation of pipeline progress and management. External comparative valuations of other companies.
Although I challenge the company's insufficient I/R communication ( very much liked today's).... the fact remains that there is a lot of sucessful medical science going on in several c/trials..
Not every thing can go our way... correct.
I would like to know the pipeline status of every TPIV trials... it seems we have not seen a positive, solid update on a long time... makes one objectively wonder of they are down played or moving towards dead. Without the merger, would TPIV be alive and growing? If not, then are we ponning hope onto the BAC group. I 'm just asking for reasonable thought and objective analysis...
MRKR has within its senior management group, experienced and well paid individuals with a well rounded set of titles. I wonder what their day to day work looks like,and the team meetings topics, direction, execution, and measurement.
We have a right to accurate information and confidence of current and near term results. Cordially, but accurately, they work for us,the owners. Start communicating with us. I have been here 3+ years and to date only have paper losses..
" ..crushed is correct." Along with the Sec filing, the company IR should have issued a press release. To be clear, hopefully, the company strenghth remains in successful science, although we rarely get updated, because it's weakness is communicating to shareholders and public.
The share price falls and yet, soon, they will be seeking another reverse split and new shares issued to raise funding. They need to understand this weakness and fix ir quickly... the institutions and retail investors will see MRKR as dead money, as it has been for 7+ months, and not buy, but sell.
WD, of course.
I also believe there is market manipulation,ie,last trade as " painted",some brokerage houses building inventory, and a small number of unconscionable ' market makers' who hold down or increase SP with vast option trading. JMO... and trading for 52 years,seeing a few terrible companies run by idiots who grabbed the assets.. and a few well run companies with exects who know what they are doing. I'm invested that Marker T is one of those.
If you believe what you posted then you believe that the market is " rigged" for instiutional trades and is "rigged" against retail investors. Perhaps you should send a note and observation of trades to the SEC.
Keep in mind, SEC reg. FD. A publicly traded company must disclose to the public any and all pertinent data or events.
I expect a P.R. issuance.
PL, once again, an honest and thoughtful reply. Admittedly, I'm in to deep, and not one for " hope and prayer." Our need is for company PR's.
Inside the merger of TPIV with Marker technology forming MRKR... I'm curious.
To know.. looking at the Talpimune c/ trials, which in the lab and c/trials in the 1990's.. costing millions and reverse splits ( I've been through 2),at this point how many are " dry holes " how many show promise. Is the company giving up on vaccine therapy or not? Who can shed real light on this?
Regards the MRKR side,are their c/trials really promising as per the video?
Lastly, if there was not the merger, would the retail investor and the few funds have " pulled the plug?"
Fair questions I think even if a few get queasy. Thoughts and facts, please?
Other than " feeling better" from mutual supportive posts, at this time IR might be our only channel to what is going on and the defending of SP.
Rough thinking here... world wide new cases of breast cancer... 2,000,000.
MRKR cost if 10% of previously given therapy cost of $300- 400,000 is $30 - 40,000...
Market penetration of 40% is 800,000.
Profit margin of 30%...( you calculate)..
Apply a P/E of 20.. what is the result.. years from now if remaining private/ public company???
Just musing...
FELIZ NAVIDAD... a very GOOD CHRISTMAS TO YOU and ALL..
PL...it is worth some to read this via you, worth much more to actually read the update, soon. You know, I thank you.
I remain long.. based on the possibilites.
But. Horse feathers to those who blame the markets for the fall in price to todays new low of $5.94. This company moves on news. Also, keep watch on the two market supporters... soon they will lower from " buy" to neutral or sell.. or from overeeight to underweight.
If you think I enjoy posting on 50% losses, you are both wrong and losing like me. Please cut the trite uninformed pumps... news is what we need.. keeping their word is what we need.. Peter, the public hopes for the science, but as a business, lives on news.. please, "present" to us too..
From a high of $10.25 to today's close of $6.08 is a loss of 41%... that is more than a correction or following the market.
Something is not right. Other than IR public posts around the combination of the two companies and the efforts gaining millions in cash... when was the latest PR
that you or any other read, and did we not expect a third qtr. MD&A?
$6.32, -.50.. down,down, and down more, and no one has an opinion? No one has any idea of what is going on inside MRKR to warrant the price decline, even when the market maker suggests a FMV of $16.00?
Anyone out there?
After hours, dropped $.28..
Some body's has some info that we don't.
A reg. FD issue?
This is crazy, after reading Alpha
One of the tenents of marketing is to over communicate, but not to over promise.
IR... please get in the game.
At this time MRKR is at $6.82, -.36...
Although low volume, there is dissatisfaction by retail shareholders that there is no phase 1 clinical update, or any update outside of presentations.
This was the pattern for years, obtain financing and leave us be.... this is not good public relations nor stock price support.
I hope that I am both correct and not alone, expecting a shareholder update on exactly what progress has been made, a near term outlook, and a sense of future commercialization .... in plain english... without ambiguities.... and this long over due communication to happen before December 18, of this year.
PH...agreed..
$175+ million are into this research to date. Along with the anticipated conference call, it would be welcomed to hear about their thoughts on "Fast track" and " right to try" status.
PH,you get it as I do.. this is a financial bad deal.. and likely to get worse..As it does, more will end the pain and move on. I can't or will not. We. Oth agree, a outward looking company understands the necessity to keep the owners updated. We are the owners. They are failing us and soon, the analysts will publish negatives...
All avoidable... communicate... communicate. Speak to the positives.. get the share price into the $10 - $15 range until Q2 or Q3, '19...
Lastly, we don't need mindless " cheerleaders."
Now at $6.73..and it is getting pain full to watch. I'm " happy " for you posters who are able to enter now and have a low average cost. People like me have been through 2 reverse share actions and some of us have an average share cost above $15. We were "all in"long ago. With $70 million and a Blue ribbon BOD and management, I clearly expected the company to give more updates and support of the stock price. Combined they got what they wanted: merge, funding, personnel, and big name close investors... may I say " Hey, hello, we the loyalists are dying out here?"
Phantom, essentially, your new opinion is that the vaccines of TPIV are of no value in determining share value. How unfortunate because what is of value is the therapeutic side of now MRKR. I disagree. Those that financed $70 million, and those who as institutions that bought in, did a thorough due dilligence on both companies having decided to combine.
Looking back the past several weeks, you seem to be softening your opinion of value. Is any of the above accurate? Are you establishing a new thought pattern on why the current depressed share price is what it is?
Rfj... I agree... not raising a ruckus here, but I suspect that the "Big" shareholder members get certain updates that are not public... we have Phantom Lord, fortunately. The MRKR I/R and P/R has not given much of anything since May regarding clinical updates and projections. The oft repeated statement that the medical test centers " hold all the cards" is wearing thin for us small retail owners.. or, at least for me.
Also,besides P.L., I have missed RKMatters and Blu... very much..all of you are great.
Yes,I have great hopes for this company and salute the "power house" management team. I simply want some updates and public press releases to be a big part of every day operations.. GLTA..
P L, good, lets keep the content conversations going. This new titled company has a great future..
P L...your tone seems to be of diminished stock results. I carefully suggest this from re reading many of your posts from the past 6-8 months.
Peter now has items to share with shareholders and the public at large. Quite certainly, we are anticipating a $20 share value and price whether before Christmas or in the first quarter.
Don't get lost in the weeds, my friend.
$7.65, at 2:30 EST, Thursday... this is more than a tumble, down almost 20% from a recent high. Until the finalization of the merge, the company is in a quiet period. But, after Tuesday, news will behin to be forth coming.. DOD/$10 grand, clinical yrials updates and more. Never panic, wearther the storm. The entire markets are in a down swing, yet the economy is strong. Don't look until after the 16th.
P/Lord, on deck, please..
Electronic proxy arrived from TDAmerica.
Burr, I'm giving it serious thought. Flight and hotel cost is near $800..
The meeting will be impactful and enjoyable to meet board members.
Actual or potential shareholders, if you believe in a future s/price of $50, you won't care if you bought in at this pricing area. GLTA.
My 55,800 are golden "yes."
Oh please,dyp, as this climbs, and it will, hundreds will be buying at least through $20.00 short term, not chasing the s/p but investing...and you know it in your mind, but not via your finger tips.
Still, nice to have you on this board.
I bought 8,100 today... at high end, so it dropped.... no worries.
I agree completely.... I/ we hope that the C/P's advance quickly, thoroughly, and successfully. Peter is a gifted person and we are fortunate to have his leadership and experience.
I am a emotionally controlled person,but am excited beyond norms.
Phone: 651-628-9259 Marker T.
Correct?
Is this accurate data on Marker Therapeutics,Inc?
33 5th Ave.NW.#800
,New Brighton. Mn. 55112
John Wilson. CE0.
3 employees.
I bought 10k this afternoon.. I had sold 20k between $9 & $13 a few weeks ago at the spike. Now looking below $6.50 to add 30k more..
How are the TPIV clinical trials progressing? A phase 1 and 2 update ought to be forth coming. Clinical trials are seperate from corporate merger work.
This good company could be a great company, and the shareholder owners should be communicated with.